Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial | |
Zhao, Yong; Jiang, Zhaoshun; Zhao, Tingbao; Ye, Mingliang; Hu, Chengjin; Zhou, Huimin; Yin, Zhaohui; Chen, Yana; Zhang, Ye; Wang, Sh 更多 | |
刊名 | BMC MEDICINE
![]() |
2013 | |
卷号 | 11 |
DOI | 10.1186/1741-7015-11-160 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5161068 |
专题 | 山东大学 |
作者单位 | 1.Univ Illinois, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60612 USA. 2.[Zhao, Yong 3.Zhang, Ye 4.W |
推荐引用方式 GB/T 7714 | Zhao, Yong,Jiang, Zhaoshun,Zhao, Tingbao,et al. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial[J]. BMC MEDICINE,2013,11. |
APA | Zhao, Yong.,Jiang, Zhaoshun.,Zhao, Tingbao.,Ye, Mingliang.,Hu, Chengjin.,...&Wang, Sh 更多.(2013).Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.BMC MEDICINE,11. |
MLA | Zhao, Yong,et al."Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial".BMC MEDICINE 11(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论